Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.93 AUD | +1.64% | +21.57% | +200.00% |
Apr. 01 | ADRs End Higher; Connect Biopharma Climbs 26% | DJ |
Mar. 28 | ADRs End Lower; NuCana Slides 15% | DJ |
Business Summary
Number of employees: 83
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Adult Stem Cell Technology
100.0
%
| 14 | 100.0 % | 11 | 100.0 % | -20.80% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia, United States and Singapore
100.0
%
| 14 | 100.0 % | 11 | 100.0 % | -20.80% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Silviu Itescu
FOU | Founder | 67 | 04-06-07 |
Andrew Chaponnel
DFI | Director of Finance/CFO | - | 12-05-31 |
Chief Operating Officer | 60 | 20-07-23 | |
Eric Rose
CTO | Chief Tech/Sci/R&D Officer | 73 | 13-04-14 |
Paul Hughes
IRC | Investor Relations Contact | - | 19-01-31 |
Niva Sivakumar
SEC | Corporate Secretary | - | 13-12-31 |
Paul Simmons
PRN | Corporate Officer/Principal | - | 10-12-31 |
General Counsel | - | 15-11-30 | |
Peter Howard
LAW | General Counsel | - | 11-06-30 |
Michael Schuster
PRN | Corporate Officer/Principal | - | 03-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Rose
CTO | Chief Tech/Sci/R&D Officer | 73 | 13-04-14 |
Joseph Swedish
CHM | Chairman | 72 | 18-06-17 |
William Burns
BRD | Director/Board Member | 76 | 14-03-05 |
Philip Facchina
BRD | Director/Board Member | 62 | 21-03-28 |
Silviu Itescu
FOU | Founder | 67 | 04-06-07 |
Jane Bell
BRD | Director/Board Member | - | 22-08-17 |
Philip Krause
BRD | Director/Board Member | - | 22-03-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,015,342,237 | 891,403,655 ( 87.79 %) | 542,903 ( 0.0535 %) | 87.79 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+200.00% | 692M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- MSB Stock
- Company Mesoblast Limited